Module
Players, power dynamics and competition
Examines the key players and power struggles shaping pricing, innovation and market access.
5 lessons • 750 XP available
Lessons
1
Why big pharma buys instead of builds: the innovation arms race with biotech
+150 XPUnderstand why big pharma acquires biotech instead of innovating internally.
2
The PBM squeeze: how middlemen quietly control drug pricing in the US
+150 XPSee how PBMs quietly shape US drug pricing.
3
Patent cliffs and the generics counterattack
+150 XPLearn how patent expiry opens the door to generics.
4
Payers as gatekeepers: how insurers and health systems decide what actually sells
+150 XPGrasp how insurers and health systems decide what actually sells.
5
Regulators as power brokers: FDA, EMA and the geopolitics of approval
+150 XPUnderstand how FDA and EMA wield approval power globally.